Davidson Kempner Capital Management’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Davidson Kempner Capital Management’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-83,332	Closed	-$1.58K	–	428
2023 Q1	$1.58K	Hold	83,332	–	–	﹤0.01%	373
2022 Q4	$10K	Hold	83,332	–	–	﹤0.01%	362
2022 Q3	$12K	Hold	83,332	–	–	﹤0.01%	453
2022 Q2	$10K	Hold	83,332	–	–	﹤0.01%	523
2022 Q1	$63K	Hold	83,332	–	–	﹤0.01%	475
2021 Q4	$50K	Hold	83,332	–	–	﹤0.01%	529
2021 Q3	$73K	Hold	83,332	–	–	﹤0.01%	459
2021 Q2	$117K	Buy	+83,332	New	+$72.7K	﹤0.01%	516

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Davidson Kempner Capital Management's PEARW Position: Q2 2023 in Review

Davidson Kempner Capital Management sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 83,332 shares — an estimated $1.58K sold.

Davidson Kempner Capital Management first reported a position in PEARW in Q2 2021 and held it in 8 quarters. The position peaked at $117K in Q2 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Davidson Kempner Capital Management reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Davidson Kempner Capital Management sold 83,332 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $1.58K.
Davidson Kempner Capital Management first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 8 quarters.
Davidson Kempner Capital Management's Pear Therapeutics, Inc. Warrant position peaked at $117K in Q2 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.